# Community Trust Bancorp Inc: financial statements, quarterly

CTBI · Nasdaq · CIK 350852 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ctbi.md) · [Financials](/companies/ctbi/financials.md) · [Filings](/companies/ctbi/filings.md) · [Insiders](/companies/ctbi/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ctbi/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [26.4](/filings/0001140361-23-051995.md) | [30.4 d](/filings/0001140361-24-009933.md) | [31.4](/filings/0001140361-24-025063.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [5.3](/filings/0001140361-24-045741.md) | [4.6 d](/filings/0001140361-26-007058.md) | [5.2](/filings/0001140361-25-018065.md) | [6.5](/filings/0001140361-25-029752.md) | [5.4](/filings/0001140361-25-040959.md) | [6.8 d](/filings/0001140361-26-007058.md) | [6.4](/filings/0001140361-26-019739.md) | [7.6](/filings/0001140361-26-031763.md) | [7.0](/filings/0001140361-25-040959.md) | [8.1 d](/filings/0001140361-26-007058.md) | [8.2](/filings/0001140361-26-019739.md) | [8.7](/filings/0001140361-26-031763.md) |
| Net income | $m | [20.6](/filings/0001140361-24-045741.md) | [18.7 d](/filings/0001140361-26-007058.md) | [18.7](/filings/0001140361-25-018065.md) | [19.5](/filings/0001140361-25-029752.md) | [22.1](/filings/0001140361-25-040959.md) | [22.5 d](/filings/0001140361-26-007058.md) | [22.0](/filings/0001140361-26-019739.md) | [24.9](/filings/0001140361-26-031763.md) | [23.9](/filings/0001140361-25-040959.md) | [27.3 d](/filings/0001140361-26-007058.md) | [27.2](/filings/0001140361-26-019739.md) | [29.6](/filings/0001140361-26-031763.md) |
| Diluted EPS | $ per share | [1.15](/filings/0001140361-24-045741.md) | not reported | [1.04](/filings/0001140361-25-018065.md) | [1.09](/filings/0001140361-25-029752.md) | [1.23](/filings/0001140361-25-040959.md) | not reported | [1.22](/filings/0001140361-26-019739.md) | [1.38](/filings/0001140361-26-031763.md) | [1.32](/filings/0001140361-25-040959.md) | not reported | [1.50](/filings/0001140361-26-019739.md) | [1.64](/filings/0001140361-26-031763.md) |
| Basic EPS | $ per share | [1.15](/filings/0001140361-24-045741.md) | not reported | [1.04](/filings/0001140361-25-018065.md) | [1.09](/filings/0001140361-25-029752.md) | [1.23](/filings/0001140361-25-040959.md) | not reported | [1.22](/filings/0001140361-26-019739.md) | [1.38](/filings/0001140361-26-031763.md) | [1.33](/filings/0001140361-25-040959.md) | not reported | [1.51](/filings/0001140361-26-019739.md) | [1.64](/filings/0001140361-26-031763.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [219](/filings/0001140361-23-051995.md) | [271](/filings/0001140361-25-006428.md) | [293](/filings/0001140361-24-025063.md) | [162](/filings/0001140361-24-036298.md) | [241](/filings/0001140361-24-045741.md) | [370](/filings/0001140361-26-007058.md) | [341](/filings/0001140361-25-018065.md) | [395](/filings/0001140361-25-029752.md) | [508](/filings/0001140361-25-040959.md) | [364](/filings/0001140361-26-031763.md) | [359](/filings/0001140361-26-019739.md) | [514](/filings/0001140361-26-031763.md) |
| Total assets | $m | [5,635](/filings/0001140361-23-051995.md) | [5,770](/filings/0001140361-25-006428.md) | [5,850](/filings/0001140361-24-025063.md) | [5,804](/filings/0001140361-24-036298.md) | [5,963](/filings/0001140361-24-045741.md) | [6,193](/filings/0001140361-26-007058.md) | [6,277](/filings/0001140361-25-018065.md) | [6,391](/filings/0001140361-25-029752.md) | [6,638](/filings/0001140361-25-040959.md) | [6,684](/filings/0001140361-26-031763.md) | [6,741](/filings/0001140361-26-019739.md) | [6,989](/filings/0001140361-26-031763.md) |
| Total liabilities | $m | [4,982](/filings/0001140361-23-051995.md) | [5,067](/filings/0001140361-25-006428.md) | [5,143](/filings/0001140361-24-025063.md) | [5,085](/filings/0001140361-24-036298.md) | [5,202](/filings/0001140361-24-045741.md) | [5,436](/filings/0001140361-26-007058.md) | [5,492](/filings/0001140361-25-018065.md) | [5,584](/filings/0001140361-25-029752.md) | [5,807](/filings/0001140361-25-040959.md) | [5,828](/filings/0001140361-26-031763.md) | [5,870](/filings/0001140361-26-019739.md) | [6,098](/filings/0001140361-26-031763.md) |
| Long-term debt | $m | not reported | [64.2](/filings/0001140361-25-006428.md) | not reported | not reported | not reported | [64.0](/filings/0001140361-26-007058.md) | not reported | not reported | not reported | [63.8](/filings/0001140361-26-007058.md) | not reported | not reported |
| Short-term borrowings | $m | not reported | [226](/filings/0001140361-25-006428.md) | not reported | not reported | not reported | [241](/filings/0001140361-26-007058.md) | not reported | not reported | not reported | [309](/filings/0001140361-26-007058.md) | not reported | not reported |
| Shareholders' equity | $m | [653](/filings/0001140361-24-045741.md) | [702](/filings/0001140361-26-007058.md) | [708](/filings/0001140361-25-029752.md) | [719](/filings/0001140361-25-040959.md) | [761](/filings/0001140361-25-040959.md) | [758](/filings/0001140361-26-031763.md) | [784](/filings/0001140361-26-031763.md) | [807](/filings/0001140361-26-031763.md) | [831](/filings/0001140361-25-040959.md) | [856](/filings/0001140361-26-031763.md) | [871](/filings/0001140361-26-031763.md) | [892](/filings/0001140361-26-031763.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [25.1 d](/filings/0001140361-24-045741.md) | [20.1 d](/filings/0001140361-26-007058.md) | [26.2](/filings/0001140361-25-018065.md) | [20.0 d](/filings/0001140361-25-029752.md) | [36.7 d](/filings/0001140361-25-040959.md) | [22.4 d](/filings/0001140361-26-007058.md) | [36.6](/filings/0001140361-26-019739.md) | [15.9 d](/filings/0001140361-26-031763.md) | [37.5 d](/filings/0001140361-25-040959.md) | [14.9 d](/filings/0001140361-26-007058.md) | [39.5](/filings/0001140361-26-019739.md) | [44.1 d](/filings/0001140361-26-031763.md) |
| Capital expenditure | $m | [2.9 d](/filings/0001140361-24-045741.md) | [1.3 d](/filings/0001140361-26-007058.md) | [2.2](/filings/0001140361-25-018065.md) | [1.5 d](/filings/0001140361-25-029752.md) | [1.3 d](/filings/0001140361-25-040959.md) | [3.0 d](/filings/0001140361-26-007058.md) | [2.1](/filings/0001140361-26-019739.md) | [2.4 d](/filings/0001140361-26-031763.md) | [1.2 d](/filings/0001140361-25-040959.md) | [2.0 d](/filings/0001140361-26-007058.md) | [1.6](/filings/0001140361-26-019739.md) | [1.0 d](/filings/0001140361-26-031763.md) |
| Dividends paid | $m | [8.2 d](/filings/0001140361-24-045741.md) | [8.2 d](/filings/0001140361-26-007058.md) | [8.3](/filings/0001140361-25-018065.md) | [8.3 d](/filings/0001140361-25-029752.md) | [8.4 d](/filings/0001140361-25-040959.md) | [8.4 d](/filings/0001140361-26-007058.md) | [8.5](/filings/0001140361-26-019739.md) | [8.5 d](/filings/0001140361-26-031763.md) | [9.5 d](/filings/0001140361-25-040959.md) | [9.5 d](/filings/0001140361-26-007058.md) | [9.6](/filings/0001140361-26-019739.md) | [9.6 d](/filings/0001140361-26-031763.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [17.9](/filings/0001140361-23-051995.md) | [17.9](/filings/0001140361-24-025063.md) | [17.9](/filings/0001140361-24-036298.md) | [17.9](/filings/0001140361-24-045741.md) | [17.9](/filings/0001140361-25-018065.md) | [18.0](/filings/0001140361-25-029752.md) | [18.0](/filings/0001140361-25-040959.md) | [18.0](/filings/0001140361-26-019739.md) | [18.0](/filings/0001140361-26-031763.md) | [18.1](/filings/0001140361-25-040959.md) | [18.1](/filings/0001140361-26-019739.md) | [18.1](/filings/0001140361-26-031763.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 18,167,954 at 2026-07-31, from the cover of the [10-Q filed 2026-08-07](/filings/0001140361-26-031763.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:22 ET. No prices; not investment advice.